Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data

Seoul National University logo

Seoul National University

Status

Not yet enrolling

Conditions

Stroke
Fall

Treatments

Device: EMG Analysis Software

Study type

Observational

Funder types

Other

Identifiers

NCT06380049
0720242110
20240012366 (Other Identifier)

Details and patient eligibility

About

The study assesses a machine learning model developed to predict fall risk among stroke patients using multi-sensor signals. This prospective, multicenter, open-label, sponsor-initiated confirmatory trial aims to validate the safety and efficacy of the model which utilizes electromyography (EMG) signals to categorize patients into high-risk or low-risk fall categories. The innovative approach hopes to offer a predictive tool that enhances preventative strategies in clinical settings, potentially reducing fall-related injuries in stroke survivors.

Full description

Objective: The primary objective is to develop and validate a machine learning-based model that uses multi-sensor (EMG) signals to identify stroke patients at high risk of falls. This model aims to improve on traditional fall risk assessments which rely heavily on physical assessments and patient history. Study Design: This is a prospective, multicenter, open-label, confirmatory clinical trial. It involves collecting EMG data from stroke patients and applying machine learning techniques to predict fall risk. The study will compare the predictive accuracy of the machine learning model against conventional fall risk assessment tools. Methods: Participants: • Sample Size: 80 stroke patients and 10 healthy adults to establish baseline EMG readings. Interventions: • Participants will undergo EMG signal collection from key lower limb muscles while performing standardized movements. Outcome Measures: Primary Outcome: Sensitivity and specificity of the machine learning model in predicting high-risk fall patients. Secondary Outcomes: Comparison of the machine learning model's predictive performance with traditional fall risk assessment tools (e.g., Berg Balance Scale). Data Collection: EMG sensors will be attached to the patients' muscles of the lower limbs. Sensors will record muscle activity during movement, which will then be analyzed using the machine learning model. The predictive model will be trained using features extracted from the EMG signals, and its performance will be validated against actual fall incidents reported during the follow-up period. Statistical Analysis: The machine learning model's efficacy will be measured through its sensitivity (ability to correctly identify high-risk patients) and specificity (ability to correctly identify low-risk patients). Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) statistics will be used to assess model performance.

Enrollment

90 estimated patients

Sex

All

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Stroke Participants

Inclusion Criteria:

  • 19 years and older
  • the onset of the stroke is less than 3months ago
  • Lower extremity weakness due to stroke (MMT =< 4 grade)
  • Cognitive ability to follow commands

Exclusion Criteria:

  • stroke recurrence
  • other neurological abnormalities (e.g. parkinson's disease).
  • severely impaired cognition
  • serious and complex medical conditions(e.g. active cancer)
  • cardiac pacemaker or other implanted electronic system

Health Participants

Inclusion Criteria:

  • 19 years and older
  • Individuals who fully understand the necessity of the study and have voluntarily consented to participate as subjects

Exclusion Criteria:

  • other neurological abnormalities (e.g. parkinson's disease).
  • severely impaired cognition
  • serious and complex medical conditions(e.g. active cancer)
  • cardiac pacemaker or other implanted electronic system

Trial contacts and locations

0

Loading...

Central trial contact

JungHyun Kim, prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems